Logo image of SOL

EMEREN GROUP LTD (SOL) Stock Fundamental Analysis

NYSE:SOL - New York Stock Exchange, Inc. - US75971T3014 - ADR - Currency: USD

1.92  +0.01 (+0.52%)

After market: 1.91 -0.01 (-0.52%)

Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to SOL. SOL was compared to 49 industry peers in the Construction & Engineering industry. The financial health of SOL is average, but there are quite some concerns on its profitability. SOL has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

SOL had negative earnings in the past year.
In the past year SOL had a positive cash flow from operations.
In multiple years SOL reported negative net income over the last 5 years.
In the past 5 years SOL always reported negative operating cash flow.
SOL Yearly Net Income VS EBIT VS OCF VS FCFSOL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M

1.2 Ratios

SOL has a Return On Assets of -1.08%. This is in the lower half of the industry: SOL underperforms 69.39% of its industry peers.
SOL has a worse Return On Equity (-1.65%) than 69.39% of its industry peers.
Industry RankSector Rank
ROA -1.08%
ROE -1.65%
ROIC N/A
ROA(3y)-1.47%
ROA(5y)-0.45%
ROE(3y)-2.16%
ROE(5y)-0.55%
ROIC(3y)N/A
ROIC(5y)N/A
SOL Yearly ROA, ROE, ROICSOL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 -40

1.3 Margins

The Gross Margin of SOL (26.87%) is better than 77.55% of its industry peers.
In the last couple of years the Gross Margin of SOL has declined.
SOL does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 26.87%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-12.71%
GM growth 5Y-1.82%
SOL Yearly Profit, Operating, Gross MarginsSOL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 -40

More info and screens

5

2. Health

2.1 Basic Checks

SOL does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for SOL has been reduced compared to 1 year ago.
The number of shares outstanding for SOL has been increased compared to 5 years ago.
Compared to 1 year ago, SOL has a worse debt to assets ratio.
SOL Yearly Shares OutstandingSOL Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M
SOL Yearly Total Debt VS Total AssetsSOL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.2 Solvency

SOL has an Altman-Z score of -0.45. This is a bad value and indicates that SOL is not financially healthy and even has some risk of bankruptcy.
SOL has a worse Altman-Z score (-0.45) than 87.76% of its industry peers.
SOL has a Debt/Equity ratio of 0.17. This is a healthy value indicating a solid balance between debt and equity.
SOL has a better Debt to Equity ratio (0.17) than 79.59% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.17
Debt/FCF N/A
Altman-Z -0.45
ROIC/WACCN/A
WACC10.1%
SOL Yearly LT Debt VS Equity VS FCFSOL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M 300M 400M

2.3 Liquidity

SOL has a Current Ratio of 4.03. This indicates that SOL is financially healthy and has no problem in meeting its short term obligations.
SOL has a Current ratio of 4.03. This is amongst the best in the industry. SOL outperforms 100.00% of its industry peers.
SOL has a Quick Ratio of 4.03. This indicates that SOL is financially healthy and has no problem in meeting its short term obligations.
With an excellent Quick ratio value of 4.03, SOL belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 4.03
Quick Ratio 4.03
SOL Yearly Current Assets VS Current LiabilitesSOL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

More info and screens

4

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 61.54% over the past year.
SOL shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -20.25%.
SOL shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -5.02% yearly.
EPS 1Y (TTM)61.54%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%137.5%
Revenue 1Y (TTM)-20.25%
Revenue growth 3Y4.93%
Revenue growth 5Y-5.02%
Sales Q2Q%-44.86%

3.2 Future

SOL is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 72.80% yearly.
SOL is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 11.79% yearly.
EPS Next Y116.83%
EPS Next 2Y72.8%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-14.03%
Revenue Next 2Y11.79%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
SOL Yearly Revenue VS EstimatesSOL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 500M 1B 1.5B
SOL Yearly EPS VS EstimatesSOL Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 -0.5 -1 -1.5 -2 -2.5

More info and screens

4

4. Valuation

4.1 Price/Earnings Ratio

SOL reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
The Price/Forward Earnings ratio is 9.27, which indicates a very decent valuation of SOL.
SOL's Price/Forward Earnings ratio is rather cheap when compared to the industry. SOL is cheaper than 95.92% of the companies in the same industry.
When comparing the Price/Forward Earnings ratio of SOL to the average of the S&P500 Index (35.58), we can say SOL is valued rather cheaply.
Industry RankSector Rank
PE N/A
Fwd PE 9.27
SOL Price Earnings VS Forward Price EarningsSOL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 -10 20 30

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, SOL is valued a bit more expensive than the industry average as 61.22% of the companies are valued more cheaply.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 26.54
SOL Per share dataSOL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4

4.3 Compensation for Growth

SOL's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as SOL's earnings are expected to grow with 72.80% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y72.8%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for SOL!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

EMEREN GROUP LTD

NYSE:SOL (7/14/2025, 5:22:23 PM)

After market: 1.91 -0.01 (-0.52%)

1.92

+0.01 (+0.52%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryConstruction & Engineering
Earnings (Last)05-14 2025-05-14/bmo
Earnings (Next)08-18 2025-08-18/amc
Inst Owners43.52%
Inst Owner Change0%
Ins Owners1.06%
Ins Owner Change0%
Market Cap98.54M
Analysts80
Price Target4.59 (139.06%)
Short Float %17.16%
Short Ratio4.19
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-92.82%
Min EPS beat(2)-384.65%
Max EPS beat(2)199.01%
EPS beat(4)2
Avg EPS beat(4)-67.17%
Min EPS beat(4)-384.65%
Max EPS beat(4)199.01%
EPS beat(8)3
Avg EPS beat(8)-824.63%
EPS beat(12)4
Avg EPS beat(12)-552.14%
EPS beat(16)6
Avg EPS beat(16)-418.14%
Revenue beat(2)0
Avg Revenue beat(2)-27.74%
Min Revenue beat(2)-40.72%
Max Revenue beat(2)-14.76%
Revenue beat(4)1
Avg Revenue beat(4)-16.47%
Min Revenue beat(4)-51.47%
Max Revenue beat(4)41.07%
Revenue beat(8)2
Avg Revenue beat(8)-16.8%
Revenue beat(12)3
Avg Revenue beat(12)-22.58%
Revenue beat(16)3
Avg Revenue beat(16)-24.91%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 9.27
P/S 1.15
P/FCF N/A
P/OCF 163.41
P/B 0.32
P/tB 0.32
EV/EBITDA 26.54
EPS(TTM)-0.1
EYN/A
EPS(NY)0.21
Fwd EY10.78%
FCF(TTM)-0.29
FCFYN/A
OCF(TTM)0.01
OCFY0.61%
SpS1.67
BVpS5.92
TBVpS5.92
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -1.08%
ROE -1.65%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 26.87%
FCFM N/A
ROA(3y)-1.47%
ROA(5y)-0.45%
ROE(3y)-2.16%
ROE(5y)-0.55%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-12.71%
GM growth 5Y-1.82%
F-Score5
Asset Turnover0.18
Health
Industry RankSector Rank
Debt/Equity 0.17
Debt/FCF N/A
Debt/EBITDA 13.21
Cap/Depr 213.85%
Cap/Sales 18.16%
Interest Coverage N/A
Cash Conversion 15.52%
Profit Quality N/A
Current Ratio 4.03
Quick Ratio 4.03
Altman-Z -0.45
F-Score5
WACC10.1%
ROIC/WACCN/A
Cap/Depr(3y)305.97%
Cap/Depr(5y)240.17%
Cap/Sales(3y)29.54%
Cap/Sales(5y)22.87%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)61.54%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%137.5%
EPS Next Y116.83%
EPS Next 2Y72.8%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-20.25%
Revenue growth 3Y4.93%
Revenue growth 5Y-5.02%
Sales Q2Q%-44.86%
Revenue Next Year-14.03%
Revenue Next 2Y11.79%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y34.63%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year107.38%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y68.45%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y101.27%
OCF growth 3YN/A
OCF growth 5YN/A